Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: HemaCare Corporation

Market Cap 346M 302M 279M 261M 490M 32.67B 493M 3.32B 1.29B 16.06B 1.3B 1.27B 55.8B P/E 2017
8.18x
P/E 2018 27.6x
Enterprise Value 336M 293M 271M 253M 476M 31.73B 479M 3.23B 1.25B 15.6B 1.26B 1.23B 54.2B EV / Sales 2017
1.29x
EV / Sales 2018 4.03x
Free-Float
94.17%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Operating Officer - 01/01/2003
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+2.79%-2.86% - - 346M
+3.03%+0.62%+52.17%+45.94% 129B
+0.49%-3.33%-0.14%+28.05% 83.63B
+0.53%+2.40%-4.96%+57.60% 25.49B
-0.73%-4.25%+7.89%+39.48% 21.43B
-0.09%-2.24%-14.75%-26.78% 19.95B
+3.58%-0.20%+6.39%+125.64% 15.4B
+0.68%+0.09%-2.79%+2.73% 14.5B
+0.85%-0.03%+53.12%+111.88% 13.46B
+1.32%+1.73%-10.77%-6.91% 12.68B
Average +1.25%-0.74%+9.57%+41.96% 37.31B
Weighted average by Cap. +1.56%-1.28%+21.19%+40.08%

Financials

2017 2018
Net sales 20.21M 17.66M 16.34M 15.25M 28.62M 1.91B 28.83M 194M 75.53M 939M 75.89M 74.24M 3.26B 28.51M 24.91M 23.04M 21.5M 40.37M 2.69B 40.67M 274M 107M 1.32B 107M 105M 4.6B
Net income 4.43M 3.87M 3.58M 3.34M 6.28M 419M 6.32M 42.57M 16.56M 206M 16.64M 16.28M 715M 4.52M 3.95M 3.65M 3.41M 6.4M 427M 6.44M 43.37M 16.88M 210M 16.96M 16.59M 729M
Net Debt -9.06M -7.92M -7.32M -6.83M -12.83M -856M -12.92M -87.01M -33.85M -421M -34.01M -33.27M -1.46B -9.9M -8.65M -8M -7.47M -14.02M -935M -14.12M -95.06M -36.99M -460M -37.16M -36.35M -1.6B
Logo HemaCare Corporation
Charles River Laboratories Cell Solutions, Inc. is a cell sourcing provider for developers of cell therapies and basic research. The Company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. It offers a comprehensive and integrated portfolio of drug development products and services available from a single global provider, spanning the continuum from early research to the support of marketed products. Its products and services include Research Models & Services, Discovery Services Safety Assessment, Laboratory Sciences, Cell and Gene Therapy CDMO Solutions, Biologics Testing Solutions, Avian Vaccine Services, QC Microbial Solutions, Scientific & Regulatory Advisory Services, and Scientific Staffing, Training & Operations Support.
Employees
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!